LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY

BACKGROUND: The aim of this study was to evaluate the safety and tolerability of 6 months of open‐label, uncontrolled extension treatment with lurasidone in patients with a diagnosis of bipolar depression who completed 6 weeks of acute treatment. METHODS: Patients completing 6 weeks of double‐blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketter, Terence A., Sarma, Kaushik, Silva, Robert, Kroger, Hans, Cucchiaro, Josephine, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069590/
https://www.ncbi.nlm.nih.gov/pubmed/26918425
http://dx.doi.org/10.1002/da.22479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069590/
https://www.ncbi.nlm.nih.gov/pubmed/26918425
http://dx.doi.org/10.1002/da.22479

Ejemplares similares